Osaic Holdings’s Prime Medicine PRME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$670 Buy
232
+68
+41% +$196 ﹤0.01% 6769
2025
Q1
$324 Sell
164
-224
-58% -$443 ﹤0.01% 6917
2024
Q4
$1.13K Sell
388
-9,513
-96% -$27.6K ﹤0.01% 6653
2024
Q3
$38.3K Sell
9,901
-800
-7% -$3.1K ﹤0.01% 4909
2024
Q2
$55K Sell
10,701
-908
-8% -$4.67K ﹤0.01% 4585
2024
Q1
$81.3K Sell
11,609
-1,961
-14% -$13.7K ﹤0.01% 4380
2023
Q4
$120K Buy
13,570
+5,608
+70% +$49.7K ﹤0.01% 4298
2023
Q3
$75.9K Buy
7,962
+1,559
+24% +$14.9K ﹤0.01% 4703
2023
Q2
$93.8K Sell
6,403
-28
-0.4% -$410 ﹤0.01% 4485
2023
Q1
$79.1K Buy
6,431
+402
+7% +$4.94K ﹤0.01% 4628
2022
Q4
$112K Buy
+6,029
New +$112K ﹤0.01% 4333